Characterization of a weakly expressed KIR2DL1 variant reveals a novel upstream promoter that controls KIR expression

Genes and Immunity

Volumn 15, Issue 7, 2014, Pages 440-448

  Wright, P W ^a   Li, H ^a   Huehn, A ^b   O'Connor, G M ^b   Cooley, S ^c   Miller, J S ^c   Anderson, S K ^a,b  

^a FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL1; PROTEIN VARIANT; TRANSCRIPTION FACTOR ZEB1; HOMEODOMAIN PROTEIN; KIR2DL1 PROTEIN, HUMAN; MESSENGER RNA; TRANSCRIPTION FACTOR; ZEB1 PROTEIN, HUMAN;

ALLELE; ARTICLE; BINDING SITE; BLOOD DONOR; CODON; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NATURAL KILLER CELL; ONCOGENE C MYC; PHENOTYPE; PROMOTER REGION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; CELL CULTURE; CHEMISTRY; GENETICS; HEK293 CELL LINE; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; TUMOR CELL LINE;

BASE SEQUENCE; BINDING SITES; CELL LINE, TUMOR; CELLS, CULTURED; HEK293 CELLS; HOMEODOMAIN PROTEINS; HUMANS; MOLECULAR SEQUENCE DATA; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RECEPTORS, KIR2DL1; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 84908239337     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2014.34     Document Type: Article

References (30)

1. Trinchieri G. Biology of natural killer cells. Adv Immunol 1989; 47: 187-376.
2. Lanier LL. NK cell recognition. Annu Rev Immunol 2005; 23: 225-274.
3. Carrington M, Norman P. The KIR Gene Cluster. National Library of Medicine (US), NCBI: Bethesda, MD, USA, 2001.
4. Anderson SK, Ortaldo JR, McVicar DW. The ever-expanding Ly49 gene family: repertoire and signaling. Immunol Rev 2001; 181: 79-89.
5. Parham P. MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol 2005; 5: 201-214.
6. Valiante NM, Uhrberg M, Shilling HG, Lienert-Weidenbach K, Arnett KL, D'Andrea A et al. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 1997; 7: 739-751.
7. Held W, Kunz B. An allele-specific, stochastic gene expression process controls the expression of multiple Ly49 family genes and generates a diverse, MHC-specific NK cell receptor repertoire. Eur J Immunol. 1998; 28: 2407-2416.
8. Santourlidis S, Trompeter HI, Weinhold S, Eisermann B, Meyer KL, Wernet P et al. Crucial role of DNA methylation in determination of clonally distributed killer cell Ig-like receptor expression patterns in NK cells. J Immunol 2002; 169: 4253-4261.
9. Chan HW, Kurago ZB, Stewart CA, Wilson MJ, Martin MP, Mace BE et al. DNA methylation maintains allele-specific KIR gene expression in human natural killer cells. J Exp Med 2003; 197: 245-255.
10. Vilches C, Gardiner CM, Parham P. Gene structure and promoter variation of expressed and nonexpressed variants of the KIR2DL5 gene. J Immunol 2000; 165: 6416-6421.
11. Gomez-Lozano N, Trompeter HI, de Pablo R, Estefania E, Uhrberg M, Vilches C. Epigenetic silencing of potentially functional KIR2DL5 alleles: implications for the acquisition of KIR repertoires by NK cells. Eur J Immunol 2007; 37: 1954-1965.
12. Stulberg MJ, Wright PW, Dang H, Hanson RJ, Miller JS, Anderson SK. Identification of distal KIR promoters and transcripts. Genes Immun 2007; 8: 124-130.
13. Cichocki F, Hanson RJ, Lenvik T, Pitt M, McCullar V, Li H et al. The transcription factor c-Myc enhances KIR gene transcription through direct binding to an upstream distal promoter element. Blood 2009; 113: 3245-3253.
14. Cichocki F, Miller JS, Anderson SK. Killer immunoglobulin-like receptor transcriptional regulation: a fascinating dance of multiple promoters. J Innate Immun 2011; 3: 242-248.
15. Saleh A, Davies GE, Pascal V, Wright PW, Hodge DL, Cho EH et al. Identification of probabilistic transcriptional switches in the Ly49 gene cluster: a eukaryotic mechanism for selective gene activation. Immunity 2004; 21: 55-66.
16. Tanamachi DM, Moniot DC, Cado D, Liu SD, Hsia JK, Raulet DH. Genomic Ly49A transgenes: basis of variegated Ly49A gene expression and identification of a critical regulatory element. J Immunol 2004; 172: 1074-1082.
17. Davies GE, Locke SM, Wright PW, Li H, Hanson RJ, Miller JS et al. Identification of bidirectional promoters in the human KIR genes. Genes Immun 2007; 8: 245-253.
18. Li H, Pascal V, Martin MP, Carrington M, Anderson SK. Genetic control of variegated KIR gene expression: polymorphisms of the bi-directional KIR3DL1 promoter are associated with distinct frequencies of gene expression. PLoS Genet 2008; 4: e1000254.
19. Cichocki F, Lenvik T, Sharma N, Yun G, Anderson SK, Miller JS. Cutting edge: KIR antisense transcripts are processed into a 28-base PIWI-like RNA in human NK cells. J Immunol 2010; 185: 2009-2012.
20. Williams TM, Moolten D, Burlein J, Romano J, Bhaerman R, Godillot A et al. Identification of a zinc finger protein that inhibits IL-2 gene expression. Science 1991; 254: 1791-1794.
21. Remacle JE, Kraft H, Lerchner W, Wuytens G, Collart C, Verschueren K et al. New mode of DNA binding of multi-zinc finger transcription factors: deltaEF1 family members bind with two hands to two target sites. EMBO J 1991; 18: 5073-5084.
22. Estefanía E, Flores R, Gomez-Lozano N, Aguilar H, Lopez-Botet M, Vilches C. Human KIR2DL5 is an inhibitory receptor expressed on the surface of NK and T lymphocyte subsets. J Immunol 2007; 178: 4402-4410.
23. Czaja K, Borer AS, Schmied L, Terszowski G, Stern M, Gonzalez A. A comprehensive analysis of the binding of anti-KIR antibodies to activating KIRs. Genes Immun 2014; 15: 33-37.
24. Stewart CA, Van Bergen J, Trowsdale J. Different and divergent regulation of the KIR2DL4 and KIR3DL1 promoters. J Immunol 2003; 170: 6073-6081.
25. Radeloff B, Nagler L, Zirra M, Ziegler A, Volz A. Specific amplification of cDNA ends (SPACE): a new tool for the analysis of rare transcripts and its application for the promoter analysis of killer cell receptor genes. DNA Seq 2005; 16: 44-52.
26. Pascal V, Stulberg MJ, Anderson SK. Regulation of class I major histocompatibility complex receptor expression in natural killer cells: one promoter is not enough! Immunol Rev 2006; 214: 9-21.
27. Fischer JC, Ottinger H, Ferencik S, Sribar M, Punzel M, Beelen DW et al. Relevance of C1 and C2 epitopes for hemopoietic stem cell transplantation: role for sequential acquisition of HLA-C-specific inhibitory killer Ig-like receptor. J Immunol 2007; 178: 3918-3923.
28. van Bergen J, Stewart CA, van den Elsen PJ, Trowsdale J. Structural and functional differences between the promoters of independently expressed killer cell Ig-like receptors. Eur J Immunol 2005; 35: 2191-2199.
29. Martin MP, Carrington M. KIR locus polymorphisms: genotyping and disease association analysis. Methods Mol Biol 2008; 415: 49-64.
30. Cooley S, Xiao F, Pitt M, Gleason M, McCullar V, Bergemann TL et al. A subpopulation of human peripheral blood NK cells that lacks inhibitory receptors for self-MHC is developmentally immature. Blood 2007; 110: 578-586.